Relaxin

From Wikipedia, the free encyclopedia

For the Miles Davis album, see Relaxin' with the Miles Davis Quintet.

Relaxin 1
Identifiers
Symbol	RLN1
HUGO	10026
Entrez	6013
OMIM	179730
Other data
Locus	Chr. 9 qter-q12

Relaxin 2
Identifiers
Symbol	RLN2
HUGO	10027
Entrez	6019
OMIM	179740
Other data
Locus	Chr. 9 qter-q12

Relaxin 3
Identifiers
Symbol	RLN3
HUGO	17135
Entrez	117579
OMIM	606855
Other data
Locus	Chr. 19 p13.3

Relaxin is a peptide hormone that was first described in 1926 by Frederick Hisaw.^[1]^[2]

Different forms of relaxin have been described: relaxin 1, 2, and 3.

1 Production
2 Structure
3 Function
4 Receptors
5 Disorders
6 References
7 External links

In the female, it is produced by the corpus luteum of the ovary, the breast and, during pregnancy, also by the placenta, chorion, and decidua.

In the male, relaxin is produced in the testes.

Structurally, relaxin is a heterodimer of two peptide chains of 24 and 29 amino acids that are linked by disulfide bridges and it appears related to insulin.

Relaxin is produced from its prohormone, “pro-relaxin”, by splitting off one additional peptide chain.

In women relaxin levels rise after ovulation as a result of its production by the corpus luteum. In the absence of pregnancy its level declines at menstruation. During the first trimester of pregnancy levels rise and additional relaxin is produced by the decidua.

Relaxin's role or necessity in human pregnancy remains under investigation, as in humans its peak is reached during the first trimester, not toward the end of pregnancy.

In animals relaxin widens the pubic bone and facilitates labor, it also softens the cervix (cervical ripening), and relaxes the uterine musculature. Thus, for a long time, relaxin was looked at as a pregnancy hormone. However, its significance may reach much further. Relaxin affects collagen metabolism, inhibiting collagen synthesis and enhancing its breakdown by increasing matrix metalloproteinases.^[3] It also enhances angiogenesis and is a potent renal vasodilator.

Relaxin interacts with the relaxin receptor LGR7 (RXFP1) and LGR8 (RXFP2) which belong to the G-protein-coupled receptor superfamily. They contain a heptahelical transmembrane domain and a large glycosylated ectodomain, distantly related to the receptors for the glycoproteohormones, such as the LH-receptor or FSH-receptor.

Relaxin receptors have been found in the heart, smooth muscle, the connective tissue, and central and autonomous nervous system.

Specific disorders related to relaxin have not been described, yet it has been suggested that it could be linked to scleroderma and to fibromyalgia.^[4]

^ http://www.time.com/time/magazine/article/0,9171,796530,00.html
^ Becker G, Hewitson T (2001). "Relaxin and renal fibrosis". Kidney Int 59 (3): 1184-5. PMID 11231378.
^ Mookerjee I, Solly N, Royce S, Tregear G, Samuel C, Tang M (2006). "Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease". Endocrinology 147 (2): 754-61. PMID 16254028.
^ Van Der Westhuizen E, Summers R, Halls M, Bathgate R, Sexton P (2007). "Relaxin receptors--new drug targets for multiple disease states". Curr Drug Targets 8 (1): 91-104. PMID 17266534.